1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. EPIGENETICS DIAGNOSTICS MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Reagents
5.3. Kits
5.4. Enzymes
5.5. Others
6. EPIGENETICS DIAGNOSTICS MARKET BY METHOD
6.1. Introduction
6.2. DNA Methylation
6.3. Histone Modification
6.4. Others
7. EPIGENETICS DIAGNOSTICS MARKET BY APPLICATION
7.1. Introduction
7.2. Oncology
7.3. Non-Oncology
8. EPIGENETICS DIAGNOSTICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. Pharmaceutical & Biotec Companies
8.3. Academic & Research Institutes
8.4. Others
9. EPIGENETICS DIAGNOSTICS MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. F. Hoffmann-La Roche Ltd
11.2. Thermo Fisher Scientific, Inc.
11.3. Element Biosciences, Inc.
11.4. Illumina, Inc.
11.5. Abcam Plc (Danaher Corporation)
11.6. QIAGEN
11.7. Merck KgaA
11.8. Zymo Research Corporation
11.9. Hologic, Inc.
11.10. Agilent Technologies, Inc.
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES